Revisiting the Effectiveness of Standard Antidepressants in Bipolar Disorder: Are Monoamine Oxidase Inhibitors Superior?

Name: Revisiting the Effectiveness of Standard Antidepressants in Bipolar Disorder: Are Monoamine Oxidase Inhibitors Superior?
SKU: 4232
Price: 30.00 USD
Availability: InStock

$30.00

EVIDENCE-BASED MEDICINE

Revisiting the Effectiveness of Standard Antidepressants in Bipolar Disorder: Are Monoamine Oxidase Inhibitors Superior?

Alan G. Mallinger, Ellen Frank, Michael E. Thase, Michelle M. Barwell, Nancy DiazGranados, David A. Luck

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 42 No. 2 Articles Tags: alan-g-mallinger, antidepressants-in-bipolar-disorder, antidepressive-agents, bipolar-disorder, clinical-trial, david-a-luckenbaugh, david-j-kupfer, depressive-disorder, ellen-frank, michael-e-thase, michelle-m-barwell, monoamine-oxidase-inhibitors, nancy-diazgranados, treatment-outcome

Description

Description

EVIDENCE BASED MEDICINE

Revisiting the Effectiveness of Standard Antidepressants in Bipolar Disorder: Are Monoamine Oxidase Inhibitors Superior?

Alan G. Mallinger, Ellen Frank, Michael E. Thase, Michelle M. Barwell, Nancy DiazGranados, David A. Luckenbaugh, David J. Kupfer

PB-42-2-2009-Mallinger

Revisiting the Effectiveness of Standard Antidepressants in Bipolar Disorder: Are Monoamine Oxidase Inhibitors Superior?

Description

Larry Alphs, MD, PhD: Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale

Trisha Suppes, MD, PhD: Awareness of Metabolic Concerns and Perceived Impact of Pharmacotherapy in Patients with Bipolar Disorder: A Survey of 500 US Psychiatrists

Ellen B. Dennehy, PhD: Concordance with Treatment Guidelines for Bipolar Disorder: Data from the Systematic Treatment Enhancement Program for Bipolar Disorder

Zonisamide for Bipolar Disorder, Mania or Mixed States by Deborah Dauphinais

Revisiting the Effectiveness of Standard Antidepressants in Bipolar Disorder: Are Monoamine Oxidase Inhibitors Superior?

Description

Related products

Larry Alphs, MD, PhD: Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale

Trisha Suppes, MD, PhD: Awareness of Metabolic Concerns and Perceived Impact of Pharmacotherapy in Patients with Bipolar Disorder: A Survey of 500 US Psychiatrists

Ellen B. Dennehy, PhD: Concordance with Treatment Guidelines for Bipolar Disorder: Data from the Systematic Treatment Enhancement Program for Bipolar Disorder

Zonisamide for Bipolar Disorder, Mania or Mixed States by Deborah Dauphinais